ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML,  | Related Articles | Citation Tracking

Reversal of corticosteroid-induced diabetes mellitis with supplemental chromium
A. Ravina*, L. Slezak*, N. Mirsky*, N. A. Bryden and R. A. Anderson
  *Department of Diabetes, The Linn Clinic, Haifa, Department of, Biology, Oranim University of Haifa, Israel   † Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, Beltsville, MD, USA
Correspondence to: Dr Richard A. Anderson, USDA, ARS, BHNRC, NRFL, Bldg. 307, Rm. 224, BARC-East, Beltsville, MD 20705–2350, USA.
e-mail: anderson@307.bhnrc.usda.gov
Copyright 1999 British Diabetic Association
KEYWORDS
chromium • corticosteroids • diabetes mellitis • glucose • insulin • steroid-induced diabetes mellitis • trace elements

ABSTRACT

 
Summary

Aims To determine if the stress of corticosteroid treatment increases chromium (Cr) losses and if corticosteroid-induced diabetes (steroid diabetes) can be reversed by supplemental chromium.

Methods The effects of corticosteroid treatment on chromium losses of 13 patients 2 days prior to steroid administration and the first 3 days following treatment were determined. Since steroid-induced diabetes was associated with increased chromium losses and insufficient dietary chromium is associated with glucose intolerance and diabetes, we treated three patients with steroid-induced diabetes with 600 μg per day of chromium as chromium picolinate.

Results Urinary chromium losses following corticosteroid treatment increased from 155 ± 28 ng/d before corticosteroid treatment to 244 ± 33 ng/d in the first 3 days following treatment. Chromium supplementation of patients with steroid-induced diabetes resulted in decreases in fasting blood glucose values from greater than 13.9 mmol/l (250 mg/dl) to less than 8.3 mmol/l (150 mg/dl). Hypoglycaemic drugs were also reduced 50% in all patients when given supplemental chromium.

Conclusions These data demonstrate that corticosteroid treatment increases chromium losses and that steroid-induced diabetes can be reversed by chromium supplementation. Follow-up, double-blind studies are needed to confirm these observations.

Diabet. Med. 16, 164–167 (1999)


Received 20 May 1998; revised 3 August 1998; accepted 18 August 1998

DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1464-5491.1999.00004.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member